140166-78-5

Basic information

• Product Name: Imidazo[1,2-a]pyridine-3-carbonitrile, 2-(4-methylphenyl)-
• CAS NO: 140166-78-5
• Molecular Formula: C15H11N3
• Molecular Weight: 233.272
• Mol File: 140166-78-5.mol

Chemical Properties

• CAS DataBase Reference: Imidazo[1,2-a]pyridine-3-carbonitrile, 2-(4-methylphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Imidazo[1,2-a]pyridine-3-carbonitrile, 2-(4-methylphenyl)-(140166-78-5)
• EPA Substance Registry System: Imidazo[1,2-a]pyridine-3-carbonitrile, 2-(4-methylphenyl)-(140166-78-5)

Safety Data

• Hazardous Substances Data: 140166-78-5(Hazardous Substances Data)

Upstream product

• 68-12-2 N,N-dimethyl-formamide 
• 65964-60-5 2-para-tolylimidazo[1,2-a]pyridine 
• 504-29-0 2-aminopyridine 
• 56578-35-9 4-methyl-cinnamaldehyde 
• 142016-38-4 2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-carbaldehyde 

Relevant articles and documents

Design, synthesis, and biological evaluation of chalcone-linked thiazole-imidazopyridine derivatives as anticancer agents

A novel library of chalcone linked thiazole-imidazopyridine (12a–j) derivatives were designed, synthesized, and their structures were characterized by 1H NMR, 13C NMR and mass spectral studies. Further, all compounds were tested for their anticancer effects on four human cancer cell lines including MCF-7 (breast carcinoma), A549 (lung carcinoma), DU-145 (prostate carcinoma) and MDA MB-231 (breast carcinoma) by employing MTT method, using etoposide as the positive control. Among them, compound 12b displayed more potent anticancer activity against four cancer cell lines when compared to the positive control.

Copper- A nd DMF-mediated switchable oxidative C-H cyanation and formylation of imidazo[1,2-: A] pyridines using ammonium iodide

The cyanation and formylation of imidazo[1,2-a]pyridines were developed under copper-mediated oxidative conditions using ammonium iodide and DMF as a nontoxic combined cyano-group source and DMF as a formylation reagent. Mechanistic studies indicate that the cyanation of imidazo[1,2-a]pyridines proceeds through a two-step sequence: Initial iodination and then cyanation. The cyanation has a broad substrate scope and high functional group tolerance, and can be safely conducted on a gram scale. A novel copper-mediated formylation using the widely available DMF as the formylation reagent and environmentally friendly molecular oxygen as the oxidant has also been developed. This protocol also provided a convenient approach for the synthesis of clinically used saripidem. This journal is

Construction of substituted 2-phenylimidazo[1,2-a]pyridine-3-nitrile by using DMF and ammonium iodide as cyanation reagents

The invention discloses a novel method for one-step construction of substituted2-phenylimidazo[1,2-a]pyridine-3-nitrile by taking DMF (N,N-dimethylformamide) and ammonium iodide as cyanation reagents.According to the method, substituted 2-phenylimidazo[1,

ANGIOTENSIN II ANTAGONIZING HETEROCYCLIC DERIVATIVES

The invention relates to compounds of the formula STR1 wherein STR2 represents a condensed or uncondensed imidazolyl ring and the rest of the variables are as defined in the specification. They are angiotensin II antagonists useful for treating hypertension, etc..

Substituted azoles, a process for their preparation, and their use

The invention relates to compounds of the formula (I) STR1 in which X, Y and Z are identical or different and are N or CR2, and the other radicals have the meaning defined in the description, a process for the preparation thereof, agents contai